O-007ZEBRA: an ACCRU/IRCI multicenter phase 2 study of pembrolizumab in patients with advanced small bowel adenocarcinoma (SBA). (2nd July 2019) - Pedersen, K; Foster, N; Overman, M; Boland, P; Kim, S; Arrambide, K; Jaszewski, B; Welch, J; Wilson, R; McWilliams, R